NCT00293917

A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

A Phase 3, Long-Term, Open Label Study to Evaluate the Safety of Twice Daily Tacrolimus Cream-B 0.1% in the Treatment of Psoriasis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 658 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

A study to assess the long-term safety of tacrolimus cream in the treatment of psoriasis

Detailed description

A long-term, open label, non-comparative, multi-center study to evaluate the safety of tacrolimus cream-B 0.1% in treating the signs and symptoms of psoriasis.

Conditions

• Psoriasis

Interventions

Type	Name	Description
DRUG	Tacrolimus Cream

Timeline

• Start date: 2006-01-01
• Primary completion: 2007-08-01
• Completion: 2007-08-01
• First posted: 2006-02-20
• Last updated: 2008-02-13

Locations

37 sites across 2 countries: United States, Canada